MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Waters Corp

Închisă

SectorSănătate

287.21 -3.35

Rezumat

Modificarea prețului

24h

Curent

Minim

284.48

Maxim

297.07

Indicatori cheie

By Trading Economics

Venit

-110M

121M

Vânzări

-211M

662M

P/E

Medie Sector

27.628

39.857

EPS

2.25

Marjă de profit

18.344

Angajați

7,600

EBITDA

-193M

152M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+33.71% upside

Dividende

By Dow Jones

Următoarele câștiguri

4 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-4.2B

18B

Deschiderea anterioară

290.56

Închiderea anterioară

287.21

Sentimentul știrilor

By Acuity

65%

35%

325 / 376 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Waters Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 14:26 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 iul. 2025, 11:08 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 iul. 2025, 18:32 UTC

Achiziții, Fuziuni, Preluări

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 iul. 2025, 18:31 UTC

Achiziții, Fuziuni, Preluări

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 iul. 2025, 16:53 UTC

Acțiuni populare

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 iul. 2025, 16:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 iul. 2025, 15:06 UTC

Achiziții, Fuziuni, Preluări

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 iul. 2025, 14:11 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 iul. 2025, 10:53 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 iul. 2025, 10:21 UTC

Achiziții, Fuziuni, Preluări

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 iul. 2025, 10:20 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 iul. 2025, 10:19 UTC

Achiziții, Fuziuni, Preluări

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 iul. 2025, 10:19 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 iul. 2025, 10:18 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 iul. 2025, 10:18 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 iul. 2025, 10:17 UTC

Achiziții, Fuziuni, Preluări

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 iul. 2025, 10:16 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 iul. 2025, 10:16 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 iul. 2025, 10:15 UTC

Achiziții, Fuziuni, Preluări

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 iul. 2025, 10:15 UTC

Achiziții, Fuziuni, Preluări

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Comparație

Modificare preț

Waters Corp Așteptări

Obiectiv de preț

By TipRanks

33.71% sus

Prognoză pe 12 luni

Medie 397 USD  33.71%

Maxim 500 USD

Minim 330 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWaters Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

6

Cumpărare

7

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

345.22 / 351.01Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

325 / 376 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.